Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jeremija Josifovski"'
Autor:
Vladimir Kovcin, Dino Tarabar, Dragutin M Kecmanovic, Zoran Petrovic, Biljana Kukic, Stojan S. Radić, Marjan Micev, Dusan Jovanovic, Svetla Jezdic, Ljiljana Radosevic-Jelic, I. Popov, Nebojsa Manojlovic, Zoran Andric, Jeremija Josifovski, Aleksandar Dagovic
Publikováno v:
Archive of Oncology, Vol 15, Iss 1-2, Pp 10-14 (2007)
Background: Bevacizumab is an anti-VEGF, humanized mAb that is the most advanced agent of its class in clinical development. Several studies have examined bevacizumab in combination with chemotherapy in the first- and second-line settings in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d750a6680879f2ff87b4f6f01478a62
http://www.doiserbia.nb.rs/img/doi/0354-7310/2007/0354-73100702010P.pdf
http://www.doiserbia.nb.rs/img/doi/0354-7310/2007/0354-73100702010P.pdf
Publikováno v:
Acta chirurgica Iugoslavica. 54:33-38
Purpose: Radiotherapy has been the standard treatment of anal canal carcinoma for the last three decades. However, there are still many open questions such as optimal radiation technique, adequate boost dose or best chemotherapy regimen. Beside cure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cb0ab9aaa24f675e9e829885c14ae1
https://doi.org/10.2298/aci0703033s
https://doi.org/10.2298/aci0703033s
Publikováno v:
Srpski arhiv za celokupno lekarstvo. 131:43-47
Treatment of inoperable (locally advanced) esophagus cancer, even today, has been a subject of numerous clinical researches. Combination of several clinical modalities is needed, of radiotherapy and chemotherapy the most frequently. This combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fa92814d54b43a64cd2e10a262ba96
https://doi.org/10.2298/sarh0302043j
https://doi.org/10.2298/sarh0302043j
Autor:
M. Durbaba, Zoran V. Krivokapić, Suzana Stojanović, Jeremija Josifovski, Ljiljana Radosevic-Jelic
Publikováno v:
Acta chirurgica Iugoslavica. 49:79-83
From February 1995 to August 2001, 34 pts with squamous cell carcinoma of the anal canal (stage T2-35,3%, stage T3-44,1%, stage T4-20,6%, stage N1-29,4%) were treated prospectively by definitive radiotherapy only, delivered with megavoltage linear ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b58879e25725fd7e647b735280d76cf
https://doi.org/10.2298/aci0202079r
https://doi.org/10.2298/aci0202079r
Autor:
Nebojsa, Manojlovic, Ljubinka, Nikolic, Dijana, Pilcevic, Jeremija, Josifovski, Dragana, Babic
Publikováno v:
Hepato-gastroenterology. 51(55)
Helicobacter pylori elicits a strong local and systemic humoral immune response, but it is not able to eliminate bacteria. Immune response may be important for the course of infection that may lead to different gastroduodenal disease. In order to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e29df33698ab055f7985b442aa4dd13
https://pubmed.ncbi.nlm.nih.gov/15011886
https://pubmed.ncbi.nlm.nih.gov/15011886
Publikováno v:
Srpski arhiv za celokupno lekarstvo. 131(1-2)
Treatment of inoperable (locally advanced) esophagus cancer, even today, has been a subject of numerous clinical researches. Combination of several clinical modalities is needed, of radiotherapy and chemotherapy the most frequently. This combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f570d79324200a8b2e268ddc9741748
https://pubmed.ncbi.nlm.nih.gov/14608862
https://pubmed.ncbi.nlm.nih.gov/14608862
Autor:
Vesna Plesinac-Karapandzic, Ljiljana Rudan, Slavica Zoranovic, Branka Mihajlovic, Jeremija Josifovski, Sonja Petrovic-Stupar, Miodrag Matijasevic, Ivanka Marjanov, Slobodanka Colakovic
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 224-224 (2002)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a847b8d90f29c1c12d710662df279df
https://doi.org/10.2298/aoo0203224r
https://doi.org/10.2298/aoo0203224r
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 149-149 (2002)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4d6c57bfb34046da18725371a7e6e08
https://doi.org/10.2298/aoo0203149j
https://doi.org/10.2298/aoo0203149j